Staff and Researcher Publications

Language

English

Publication Date

8-1-2022

Journal

Biological Psychiatry

DOI

10.1016/j.biopsych.2021.11.007

PMID

35063186

PMCID

PMC9124238

PubMedCentral® Posted Date

8-1-2023

PubMedCentral® Full Text Version

Author MSS

Abstract

The success of deep brain stimulation (DBS) for treating Parkinson's disease has led to its application to several other disorders, including treatment-resistant depression. Results with DBS for treatment-resistant depression have been heterogeneous, with inconsistencies largely driven by incomplete understanding of the brain networks regulating mood, especially on an individual basis. We report results from the first subject treated with DBS for treatment-resistant depression using an approach that incorporates intracranial recordings to personalize understanding of network behavior and its response to stimulation. These recordings enabled calculation of individually optimized DBS stimulation parameters using a novel inverse solution approach. In the ensuing double-blind, randomized phase incorporating these bespoke parameter sets, DBS led to remission of symptoms and dramatic improvement in quality of life. Results from this initial case demonstrate the feasibility of this personalized platform, which may be used to improve surgical neuromodulation for a vast array of neurologic and psychiatric disorders.

Keywords

Deep Brain Stimulation, Depression, Depressive Disorder, Treatment-Resistant, Double-Blind Method, Humans, Parkinson Disease, Quality of Life, deep brain stimulation, neuromodulation, stereo-EEG, network, epilepsy, depression

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.